FDA clearance

FDA clearance

Topcon Medical Systems has announced that its PASCAL® Synthesis TwinStar™ laser, (combined 577Nm and 638Nm) has received FDA 510(k) clearance. (K170409) “The Synthesis TwinStar further expands the PASCAL line of laser photocoagulators offering the ability to treat retinal disorders with a 577Nm yellow wavelength or with a 638Nm red wavelength,” said a spokeswoman. ““The yellow module allows doctors to treat with a single spot as well as with a variety of patterns and four spot sizes. The yellow module can also be used with the optional Endpoint Management software for sub-threshold procedures. The red wavelength, ideal for targeting choroidal vessels in the neovascular membrane, is for single spot treatments and has two different spot sizes,” she said. www.topcon.com

Latest Articles

Nutrition and the Eye: A Recipe for Success

A look at the evidence for tasty ways of lowering risks and improving ocular health.

New Award to Encourage Research into Sustainable Practices

Sharing a Vision for the Future

ESCRS leaders update Trieste conference on ESCRS initiatives.

Extending Depth of Satisfaction

The ESCRS Eye Journal Club discuss a new study reviewing the causes and management of dissatisfaction after implantation of an EDOF IOL.

Conventional Versus Laser-Assisted Cataract Surgery

Evidence favours conventional technique in most cases.

AI Scribing and Telephone Management

Automating note-taking and call centres could boost practice efficiency.

AI Analysis and the Cornea

A combination of better imaging and AI deep learning could significantly improve corneal imaging and diagnosis.

Cooking a Feast for the Eyes

A cookbook to promote ocular health through thoughtful and traditional cuisine.

Need to Know: Spherical Aberration

Part three of this series examines spherical aberration and its influence on higher-order aberrations.

Generating AI’s Potential

How generative AI impacts medicine, society, and the environment.